Ampio Pharmaceuticals
AMPE
#10613
Rank
HK$0.04 M
Marketcap
HK$0.04048
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Ampio Pharmaceuticals (AMPE)

EPS in 2023 (TTM): -HK$133.71

According to Ampio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$132.65. In 2022 the company made an earnings per share (EPS) of -HK$168.77 an increase over its 2021 EPS that were of -HK$210.18.

EPS history for Ampio Pharmaceuticals from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$133.71-20.77%
2022-HK$168.77-19.7%
2021-HK$210.18-0%
2020-HK$210.18-10%
2019-HK$233.54-121.74%
2018HK$1,074-158.23%
2017-HK$1,845119.44%
2016-HK$840.74-41.94%
2015-HK$1,448-18.42%
2014-HK$1,77520.63%
2013-HK$1,47185.29%
2012-HK$794.03-52.11%
2011-HK$1,65844.9%
2010-HK$1,144390%
2009-HK$233.54233.33%
2008-HK$70.06-0%
2007-HK$70.06
2006N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Aerie Pharmaceuticals
AERI
-HK$5.84-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.27-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
HK$49.28-137.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.72-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$338.16-354.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.39-110.09%๐Ÿ‡บ๐Ÿ‡ธ USA